Jacobi Capital Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $8.22M | Sell |
32,674
-1
| -0% | -$215 | 0.4% | 43 |
|
|
2026
Q1 | $7.11M | Sell |
32,675
-198
| -0.6% | -$43.9K | 0.4% | 45 |
|
|
2025
Q4 | $7.51M | Sell |
32,873
-672
| -2% | -$153K | 0.44% | 38 |
|
|
2025
Q3 | $7.77M | Sell |
33,545
-122
| -0.4% | -$24.8K | 0.47% | 34 |
|
|
2025
Q2 | $6.25M | Buy |
33,667
+496
| +1% | +$92.2K | 0.41% | 39 |
|
|
2025
Q1 | $6.95M | Buy |
33,171
+202
| +0.6% | +$39.3K | 0.51% | 29 |
|
|
2024
Q4 | $5.86M | Sell |
32,969
-270
| -0.8% | -$49.6K | 0.44% | 41 |
|
|
2024
Q3 | $6.56M | Buy |
33,239
+675
| +2% | +$126K | 0.5% | 33 |
|
|
2024
Q2 | $5.59M | Buy |
32,564
+134
| +0.4% | +$22.2K | 0.48% | 31 |
|
|
2024
Q1 | $5.91M | Buy |
32,430
+669
| +2% | +$115K | 0.55% | 27 |
|
|
2023
Q4 | $4.92M | Buy |
31,761
+464
| +1% | +$67.6K | 0.5% | 32 |
|
|
2023
Q3 | $4.67M | Sell |
31,297
-71
| -0.2% | -$10.4K | 0.53% | 31 |
|
|
2023
Q2 | $4.23M | Sell |
31,368
-1,344
| -4% | -$197K | 0.47% | 38 |
|
|
2023
Q1 | $5.21M | Buy |
32,712
+301
| +0.9% | +$46K | 0.62% | 27 |
|
|
2022
Q4 | $5.24M | Sell |
32,411
-348
| -1% | -$53.4K | 0.66% | 28 |
|
|
2022
Q3 | $4.4M | Sell |
32,759
-322
| -1% | -$46.2K | 0.6% | 31 |
|
|
2022
Q2 | $5.07M | Sell |
33,081
-49
| -0.1% | -$7.49K | 0.67% | 27 |
|
|
2022
Q1 | $5.37M | Sell |
33,130
-459
| -1% | -$66.7K | 0.64% | 26 |
|
|
2021
Q4 | $4.55M | Buy |
33,589
+1,503
| +5% | +$178K | 0.54% | 29 |
|
|
2021
Q3 | $3.46M | Buy |
32,086
+2,301
| +8% | +$263K | 0.44% | 37 |
|
|
2021
Q2 | $3.35M | Buy |
29,785
+1,189
| +4% | +$134K | 0.44% | 35 |
|
|
2021
Q1 | $3.09M | Buy |
28,596
+510
| +2% | +$54.6K | 0.46% | 38 |
|
|
2020
Q4 | $3.03M | Sell |
28,086
-100
| -0.4% | -$9.61K | 0.48% | 34 |
|
|
2020
Q3 | $2.43M | Sell |
28,186
-1,972
| -7% | -$186K | 0.43% | 36 |
|
|
2020
Q2 | $2.95M | Buy |
30,158
+3,476
| +13% | +$306K | 0.55% | 30 |
|
|
2020
Q1 | $2.09M | Sell |
26,682
-1,258
| -5% | -$107K | 0.45% | 40 |
|
|
2019
Q4 | $2.41M | Buy |
27,940
+1,020
| +4% | +$84.7K | 0.44% | 45 |
|
|
2019
Q3 | $2.05M | Buy |
26,920
+1,027
| +4% | +$70.4K | 0.41% | 46 |
|
|
2019
Q2 | $1.86M | Buy |
25,893
+15,918
| +160% | +$1.25M | 0.38% | 52 |
|
|
2019
Q1 | $804K | Buy |
9,975
+1,464
| +17% | +$120K | 0.21% | 79 |
|
|
2018
Q4 | $785K | Buy |
8,511
+2,171
| +34% | +$191K | 0.21% | 72 |
|
|
2018
Q3 | $600K | Buy |
6,340
+1,061
| +20% | +$101K | 0.16% | 86 |
|
|
2018
Q2 | $489K | Buy |
5,279
+3,215
| +156% | +$314K | 0.14% | 97 |
|
|
2018
Q1 | $189K | Buy |
2,064
+959
| +87% | +$105K | 0.06% | 188 |
|
|
2017
Q4 | $110K | Sell |
1,105
-397
| -26% | -$37.4K | 0.04% | 244 |
|
|
2017
Q3 | $136K | Buy |
1,502
+194
| +15% | +$14.8K | 0.05% | 196 |
|
|
2017
Q2 | $94K | Sell |
1,308
-70
| -5% | -$4.71K | 0.04% | 214 |
|
|
2017
Q1 | $90K | Sell |
1,378
-113
| -8% | -$7.1K | 0.05% | 169 |
|
|
2016
Q4 | $91K | Sell |
1,491
-687
| -32% | -$41.9K | 0.06% | 146 |
|
|
2016
Q3 | $137K | Hold |
2,178
| – | – | 0.06% | 122 |
|
|
2016
Q2 | $138K | Buy |
+2,178
| New | +$133K | 0.07% | 112 |
|
Other funds holding ABBV
ECSS
ATO
Jacobi Capital Management's ABBV Position: Q2 2026 in Review
Jacobi Capital Management reduced its AbbVie (ABBV) stake by 0% in Q2 2026, selling an estimated $215 and leaving 32,674 shares worth $8.22M. The position accounts for 0.4% of the portfolio, ranked #43.
Jacobi Capital Management first reported a position in ABBV in Q2 2016 and has held it in 41 quarters since. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Jacobi Capital Management held 32,674 shares of AbbVie worth $8.22M as of Q2 2026.
- Jacobi Capital Management sold 1 AbbVie share in Q2 2026, an estimated $215.
- AbbVie made up 0.4% of Jacobi Capital Management's portfolio in Q2 2026, its #43 holding.
- Jacobi Capital Management first reported a position in AbbVie in Q2 2016 and has held it in 41 quarters since.
- 2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Jacobi Capital Management's 13F filing for Q2 2026, filed 31 Jul 2026.